Literature DB >> 21437732

A peculiar constellation of tau pathology defines a subset of dementia in the elderly.

Gabor G Kovacs1, Kinga Molnár, Lajos László, Thomas Ströbel, Gergö Botond, Selma Hönigschnabl, Angelika Reiner-Concin, Miklós Palkovits, Peter Fischer, Herbert Budka.   

Abstract

Sporadic tauopathies are characterized by differential cellular and topographical predominance of phospho-tau immunoreactivity and biochemical distinction of the tau protein. Established entities include progressive supranuclear palsy, corticobasal degeneration, Pick's disease, and argyrophilic grain disease. During a community-based longitudinal study on aging, we detected tau pathologies not compatible with these categories. We immunostained for different phospho-tau epitopes, 4R and 3R tau isoforms, α-synuclein, amyloid-β, and phospho-TDP-43, analyzed the MAPT and ApoE genes, and performed western blotting for the tau protein. The mean age of patients (4 women, 3 men) was 83.8 years. Clinical presentations combined dementia with psychiatric symptoms and/or parkinsonism. In addition to neurofibrillary tangles and diffuse neuronal cytoplasmic tau immunoreactivity, the neuropathology was characterized by peculiar cytopathologies (diffuse granular immunopositivity of astrocytic processes and patchy accumulation of thin threads) in a distinctive distribution (frontal and temporal cortices, hippocampus, amygdala, basal ganglia, locus coeruleus, and substantia nigra). Argyrophilic grains were detected in four patients. Few to moderate densities of neuritic plaques but widespread phospho-TDP-43 pathology was observed in five patients. There was variability in the H1/H2 and ApoE alleles and biochemical features of tau protein. We propose these cases as complex tauopathy with a characteristic constellation: some features of primary tauopathies and Alzheimer's disease mixed with additional cytopathologies including a distinctive astrogliopathy, in a characteristic distribution of lesions. These complex tauopathies in the elderly deserve specific diagnostic and eventually therapeutic considerations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21437732     DOI: 10.1007/s00401-011-0819-x

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  28 in total

1.  Nigral Tau pathology and striatal amyloid-β deposition does not correlate with striatal dopamine deficit in Alzheimer's disease.

Authors:  Tabea H Schauer; Maximilian Lochner; Gabor G Kovacs
Journal:  J Neural Transm (Vienna)       Date:  2012-06-05       Impact factor: 3.575

2.  Squirrel monkeys (Saimiri sciureus) infected with the agent of bovine spongiform encephalopathy develop tau pathology.

Authors:  P Piccardo; J Cervenak; O Yakovleva; L Gregori; K Pomeroy; A Cook; F S Muhammad; T Seuberlich; L Cervenakova; D M Asher
Journal:  J Comp Pathol       Date:  2011-10-20       Impact factor: 1.311

3.  Connexin-43 and aquaporin-4 are markers of ageing-related tau astrogliopathy (ARTAG)-related astroglial response.

Authors:  G G Kovacs; A Yousef; S Kaindl; V M Lee; J Q Trojanowski
Journal:  Neuropathol Appl Neurobiol       Date:  2017-08-25       Impact factor: 8.090

Review 4.  Protein astrogliopathies in human neurodegenerative diseases and aging.

Authors:  Gabor G Kovacs; Virginia M Lee; John Q Trojanowski
Journal:  Brain Pathol       Date:  2017-09       Impact factor: 6.508

5.  Evaluating the Patterns of Aging-Related Tau Astrogliopathy Unravels Novel Insights Into Brain Aging and Neurodegenerative Diseases.

Authors:  Gabor G Kovacs; John L Robinson; Sharon X Xie; Edward B Lee; Murray Grossman; David A Wolk; David J Irwin; Dan Weintraub; Christopher F Kim; Theresa Schuck; Ahmed Yousef; Stephanie T Wagner; Eunran Suh; Vivianna M Van Deerlin; Virginia M-Y Lee; John Q Trojanowski
Journal:  J Neuropathol Exp Neurol       Date:  2017-04-01       Impact factor: 3.685

6.  Familial behavioral variant frontotemporal dementia associated with astrocyte-predominant tauopathy.

Authors:  Isidre Ferrer; Andrea Legati; J Carlos García-Monco; Marian Gomez-Beldarrain; Margarita Carmona; Rosa Blanco; William W Seeley; Giovanni Coppola
Journal:  J Neuropathol Exp Neurol       Date:  2015-04       Impact factor: 3.685

7.  Practical Considerations in the Diagnosis of Mild Chronic Traumatic Encephalopathy and Distinction From Age-Related Tau Astrogliopathy.

Authors:  Ann C McKee; Thor D Stein; John F Crary; Kevin F Bieniek; Robert C Cantu; Gabor G Kovacs
Journal:  J Neuropathol Exp Neurol       Date:  2020-08-01       Impact factor: 3.685

8.  Clinicopathological outcomes of prospectively followed normal elderly brain bank volunteers.

Authors:  Brittany N Dugger; Joseph G Hentz; Charles H Adler; Marwan N Sabbagh; Holly A Shill; Sandra Jacobson; John N Caviness; Christine Belden; Erika Driver-Dunckley; Kathryn J Davis; Lucia I Sue; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2014-03       Impact factor: 3.685

Review 9.  Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy.

Authors:  Gabor G Kovacs; Isidro Ferrer; Lea T Grinberg; Irina Alafuzoff; Johannes Attems; Herbert Budka; Nigel J Cairns; John F Crary; Charles Duyckaerts; Bernardino Ghetti; Glenda M Halliday; James W Ironside; Seth Love; Ian R Mackenzie; David G Munoz; Melissa E Murray; Peter T Nelson; Hitoshi Takahashi; John Q Trojanowski; Olaf Ansorge; Thomas Arzberger; Atik Baborie; Thomas G Beach; Kevin F Bieniek; Eileen H Bigio; Istvan Bodi; Brittany N Dugger; Mel Feany; Ellen Gelpi; Stephen M Gentleman; Giorgio Giaccone; Kimmo J Hatanpaa; Richard Heale; Patrick R Hof; Monika Hofer; Tibor Hortobágyi; Kurt Jellinger; Gregory A Jicha; Paul Ince; Julia Kofler; Enikö Kövari; Jillian J Kril; David M Mann; Radoslav Matej; Ann C McKee; Catriona McLean; Ivan Milenkovic; Thomas J Montine; Shigeo Murayama; Edward B Lee; Jasmin Rahimi; Roberta D Rodriguez; Annemieke Rozemüller; Julie A Schneider; Christian Schultz; William Seeley; Danielle Seilhean; Colin Smith; Fabrizio Tagliavini; Masaki Takao; Dietmar Rudolf Thal; Jon B Toledo; Markus Tolnay; Juan C Troncoso; Harry V Vinters; Serge Weis; Stephen B Wharton; Charles L White; Thomas Wisniewski; John M Woulfe; Masahito Yamada; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2015-12-10       Impact factor: 17.088

10.  The Tau/A152T mutation, a risk factor for frontotemporal-spectrum disorders, leads to NR2B receptor-mediated excitotoxicity.

Authors:  Jochen Martin Decker; Lars Krüger; Astrid Sydow; Frank Ja Dennissen; Zuzana Siskova; Eckhard Mandelkow; Eva-Maria Mandelkow
Journal:  EMBO Rep       Date:  2016-03-01       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.